Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy.
Department of Medical and Surgical Sciences, Magna Græcia University, Catanzaro, Italy.
Minerva Chir. 2020 Apr;75(2):77-82. doi: 10.23736/S0026-4733.18.07757-X. Epub 2018 Jun 29.
Laparoscopic sleeve gastrectomy (LSG) represents the most performed bariatric surgical procedure worldwide. Morbid Overweight in elderly patients is becoming a significant health problem even in Italy. As well as in younger age groups, bariatric surgery could be indicated even in this subset of patients. However the advantages and results of LSG in patients over 60 years old have received minimal attention.
The records of 375 patients underwent LSG between 2008 and 2016 were reviewed. In the entire series 18 patients were aged 60 years or older at the time of surgery. Since a 3 years follow-up was available for 12 patients out of the 18 aged over 60 we included in the study only these. General epidemiologic data, clinical findings, BMI and comorbidities surgical treatment and follow-up data were collected; postoperative measurements such as operative time, intraoperative complications, mortality rate, length of stay, incidence of early and late complications, Body mass Index (BMI), excess weight loss rate (EWL%) and comorbidities resolution were also recorded.
LSG was successfully performed for all geriatric patients. Global complications rate was 16.6% At 3 years mean BMI was 34.4±3.8 with a mean EWL% 66.1±31.9. Postoperative resolution of obesity comorbidities was observed; Hypertension (71.4%), type 2 Diabetes Mellitus (T2DM) (50.0%), obstructive sleep apnea syndrome (OSAS) (66.6%) respectively. No intraoperative complications or mortality were recorded.
LSG offered cure in geriatric patients affected by morbid obesity for weight loss and comorbidities resolution. Larger studies are necessary to analyze and minimize the incidence of postoperative complications associated to this surgical procedure in elderly patients.
腹腔镜袖状胃切除术(LSG)是全球开展最多的减重手术。即使在意大利,老年肥胖患者的病态超重也成为了一个严重的健康问题。与年轻患者一样,肥胖症患者也可以接受减重手术。然而,LSG 在 60 岁以上患者中的优势和结果尚未得到充分关注。
回顾了 2008 年至 2016 年间接受 LSG 的 375 例患者的记录。在整个系列中,18 例患者在手术时年龄为 60 岁或以上。由于 18 例 60 岁以上患者中有 12 例可获得 3 年随访,因此我们仅将这 12 例纳入研究。收集了一般人口统计学数据、临床发现、BMI 和合并症、手术治疗和随访数据;还记录了术后测量值,如手术时间、术中并发症、死亡率、住院时间、早期和晚期并发症的发生率、体重指数(BMI)、多余体重减轻率(EWL%)和合并症的缓解情况。
LSG 成功地为所有老年患者实施。总的并发症发生率为 16.6%。3 年后平均 BMI 为 34.4±3.8,平均 EWL%为 66.1±31.9。观察到肥胖合并症得到了缓解;高血压(71.4%)、2 型糖尿病(T2DM)(50.0%)、阻塞性睡眠呼吸暂停综合征(OSAS)(66.6%)。无术中并发症或死亡。
LSG 为病态肥胖的老年患者提供了减肥和合并症缓解的治疗方法。需要进一步的研究来分析和降低老年患者接受这种手术的术后并发症发生率。